medroxyprogesterone acetate has been researched along with Colorectal Neoplasms, Hereditary Nonpolyposis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd-Rogers, S; Broaddus, RR; Chen, LM; Conrad, P; Cornelison, T; Daniels, MS; Gershenson, DM; Loose, DS; Lu, KH; Lynch, H; Milbourne, A; Munsell, MF; Nogueras-Gonzalez, GM; Rubin, M; Yates, MS | 1 |
1 trial(s) available for medroxyprogesterone acetate and Colorectal Neoplasms, Hereditary Nonpolyposis
Article | Year |
---|---|
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Colorectal Neoplasms, Hereditary Nonpolyposis; Contraceptives, Oral; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Medroxyprogesterone Acetate; Middle Aged; Mutation; Prognosis; Prospective Studies | 2013 |